Team at the Center

Series Program Overview

As new data continue to emerge for treatment options for intermediate-stage hepatocellular carcinoma (HCC), it is more important than ever for multidisciplinary health care providers, especially interventional radiologists and medical oncologists, to stay up to date with newly approved therapies and evolving therapeutic strategies. This Phone-a-Friend series will invite experts in the field to discuss typical case scenarios and real-world topics such as first-line therapeutic decision-making for intermediate-stage HCC, treatment sequencing after locoregional therapy failure, and monitoring for and mitigating systemic therapy–related adverse events. Check back regularly for new episodes!